Impact of primary PCI volume on hospital mortality in STEMI patients: does time-to-presentation matter?

Eliano Pio Navarese1, Stefano De Servi, Alessandro Politi

  • 1Department of Cardiovascular Diseases, Azienda Ospedaliera Ospedale Civile di Legnano, Legnano (Milan), Italy. eliano.navarese@alice.it

Insights

High-volume percutaneous coronary intervention (PCI) centers reduce ST-elevation myocardial infarction (STEMI) mortality, especially for patients arriving within 90 minutes. This benefit is time-dependent and more pronounced in high-risk individuals.

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology
  • Health Services Research

Background:

  • The relationship between hospital procedural volume and patient outcomes is crucial for healthcare policy.
  • Limited data exist on how time-to-presentation influences the impact of primary percutaneous coronary intervention (PCI) volume on mortality in ST-elevation myocardial infarction (STEMI) patients.

Purpose of the Study:

  • To evaluate the impact of hospital primary PCI volume on in-hospital mortality in STEMI patients.
  • To assess how this relationship is modified by different times-to-presentation and patient risk profiles.

Main Methods:

  • A prospective registry analysis of 2,558 STEMI patients in the Lombardy region, Northern Italy.
  • Investigation of primary PCI volume's effect on mortality across distinct time-to-presentation intervals (≤90 min, >90–180 min, >180 min).
  • Risk stratification using the TIMI Risk Index.

Main Results:

  • A significant inverse correlation was observed between hospital primary PCI volume and risk-adjusted mortality (r = -0.9, P < 0.001).
  • High primary PCI volumes were strongly associated with improved survival for patients presenting within 90 minutes (AUC = 0.73, P < 0.0001).
  • A threshold of >66 primary PCIs/year was optimal for benefit within 90 minutes, particularly for high-TIMI Risk Index patients. Benefits diminished significantly for presentations >90 minutes.

Conclusions:

  • The mortality benefit of high-volume primary PCI centers for STEMI patients is time-dependent and influenced by patient risk.
  • The greatest survival advantage is achieved in high-risk patients treated promptly (within 90 minutes) at high-volume centers.
  • Optimizing treatment strategies requires considering both hospital volume and patient presentation time.

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...